/
SPONSORED
Polish start-up taps AI to help manage blood supplies
Founded in 2019 by two young doctors, the company has developed an AI-powered smart assistant to support crucial decision-making in blood transfusions.
/
SPONSORED
Feds release AI strategic plan for HHS
With the release, HHS now has an overarching strategy in place to guide the agency’s ongoing and upcoming efforts involving AI.
/
SPONSORED
ONC launches challenge to expand research data supply
The Synthetic Health Data Challenge encourages researchers and developers to validate the realism of synthetic health records generated by Synthea and spur novel uses of synthetic health data.
/
SPONSORED
Employers aim for safe workplaces with AI-driven Passport
By enabling employees and customers to securely assess their health status on their mobile devices, Passport is designed to help organizations re-open safely and maintain a healthy work environment.
/
SPONSORED
How AI can help docs keep their paperwork in order
With AI, says one stakeholder, the next frontier in healthcare is ensuring that everyone across the healthcare ecosystem has actionable insights.
/
SPONSORED
AI-driven command center helps Washington State system manage COVID crush
Since it launched, say stakeholders, CHI Franciscan’s Mission Control has had tremendous success managing capacity, transfers, patient placement and staffing, all in the middle of a pandemic.
/
SPONSORED
Tech partners unveil life science data platform
Designed to work across many different types of biomedical information, stakeholders say Terra simplifies a range of processes so, among other outcomes, researchers can analyze and share data they have generated.
/
SPONSORED
Researchers: juries not inclined to jump to AI malpractice conclusions
Despite the promise of AI to improve patient outcomes, legal scholars have previously cautioned that tort law may create a substantial legal barrier to physician acceptance of AI recommendations.
/
SPONSORED
FDA releases AI-based software action plan
Via its participation in community efforts such as standards development and patient-focused programs, the FDA aims to support the transparency of and trust in AI/ML-based technologies.